Ondansetron Injection, Solution
Product Images NDC 0409-4755
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0409-4755). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Ondansetron 02)
Principal Display Panel (2 mL Vial Label)
Principal Display Panel (2 mL Vial Carton)
Principal Display Panel (20 mL Vial Label)
This is a 20 mL Multi-dose Vial of Ondansetron injection, USP, which contains 2 mg/mL. It is for IV or IM injection and is sterile. Each 1 mL of aqueous solution contains ondansetron 2mg. The vial contains buffers, preservatives and sodium chloride. The package insert contains dosage and administration details. It needs to be stored at 20 to 25°C and protected from light. The manufacturer is Hospira, Inc, Lake Forest IL 60045 USA.*
Principal Display Panel (20 mL Vial Carton)
This is a description of a medication labeled as Ondansetron Injection USP with a 2mg dosage in a 20mL multi-dose vial. The medication contains sodium chloride and methylparaben and is intended for intravenous or intramuscular injection. It should be stored at a temperature of 2 to 8 degrees Celsius and protected from light.*
Principal Display Panel (20 mL Vial Tray)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.